Biofilm
can protect bacteria from immune attacks and antibiotic
inhibition, and bacterial biofilm hosted in implanted materials and
medical devices is a serious threat for modern medical system. Herein,
we report biofilm-responsive caged guanidine nanoparticles (CGNs)
to deeply penetrate and accumulate in bacterial biofilm, and then
efficient photothermal eradication of bacterial biofilm is achieved
upon NIR laser irradiation via the proof-of-concept formulation of
photothermal agents in CGNs. In physiological conditions and blood
circulation, CGNs are negatively charged by masking the positive charge
of guanidine via covalent modification with acid-cleavable moieties,
exhibiting high biocompatibility and minimal hemolysis. Whereas upon
blood circulation and passive accumulation at infected implant sites,
CGNs are self-adaptive in acidic biofilm to release the protective
caging group and expose native guanidine moieties, which can promote
nanoparticle deep biofilm penetration and bacteria adhesion as well
as membrane fusion. After that, remarkable photothermal effect with
a high photothermal conversion efficiency of ∼40.9% can eradicate
implant biofilm upon NIR laser irradiation. It can efficiently treat S. aureus biofilm-infected implant catheters in vivo via only one single treatment in a mouse model,
exhibiting ∼99.6% bacteria inhibition ratio. Apart from this
proof-of-concept work, current guanidine-caged biofilm responsive
polymeric nanoparticles are promising general vectors to treat biofilm
and resistant pathogens in medicine and daily healthcare.